FLT3 and acute myeloid leukemia: Although mutations in FLT3 have been well-documented in cases of acute myeloid leukemia (AML) and other hematological malignancies [63], there is currently no substantial evidence demonstrating that FLT3 plays a role in the tumorigenesis of CRC.